BD ProEx C immunostaining in extramammary Paget's disease and perineal melanoma.
Where this comes from
- Record sourced from PubMed, PMID 18931649.
- Also identified by DOI 10.1038/modpathol.2008.171.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The differential diagnosis of perineal biopsies can include squamous intraepithelial lesions, extramammary Paget's disease, and melanoma. Less frequently two of these lesions coexist. BD ProEx C is a recently developed immunoassay that targets expression of two genes shown to be associated with cervical cancer. Immunostaining for ProEx C has been validated in cervical cytology and positive staining has also been shown to be strongly associated with human papilloma virus (HPV)-induced cervical and anal intraepithelial neoplasia in biopsies. We observed positive staining for ProEx C in Paget cells in all of 26 cases of Paget's disease irrespective of tissue site (extramammary, mammary) and in melanoma cells in all of 12 cases of primary perineal melanoma with immunostaining in >50% of malignant cells in 73% of Paget disease cases and 43% of perineal melanoma cases. Positive staining was heterogeneous and exclusively nuclear in all cases. In situ hybridization was negative for low-risk and high-risk HPV subtypes in all Paget and melanoma cases that were tested. Currently neither of these lesions is known to be HPV related although according to the literature the possibility of a role for HPV in melanoma is still unsettled. Relevant literature is reviewed.
Medical subject headings
- Antigens, Neoplasm
- Anus Neoplasms
- Cell Cycle Proteins
- DNA Topoisomerases, Type II
- DNA-Binding Proteins
- Melanoma
- Nuclear Proteins
- Paget Disease, Extramammary
- Perineum
- Reagent Kits, Diagnostic
- Vaginal Neoplasms
- Vulvar Neoplasms